HYDERABAD, Jan 21 (Reuters) - Indian drugmaker Dr Reddy's (REDY.NS), opens new tab, which reported a smaller-than-expected fall in quarterly profit on Wednesday, said that it has received an approval ...

Here’s a trio for you: Taylor Swift’s record-shattering The Life Of A Showgirl; Bad Bunny’s culture-defining residency in Puerto Rico (and subsequent, idiot-bothering confirmation for the Super Bowl ...

What’s going on here? Dr Reddy’s Laboratories saw its shares tumble this week after Canadian regulators issued a non-compliance notice for its semaglutide injection, sending the stock down more than 5 ...

Nagaveni M. Reddy, DDS passed away peacefully surrounded by family on August 20, 2025 after a 6 year battle with cancer. Dr. Reddy practiced dentistry in Milwaukee for over 30 years, where she also ...

Stockbridge Select Board Chair Jamie Minacci (middle) discusses moving forward with the group's selection of Robert Navin to be the town's next Highway Superintendent during their Aug. 12 meeting.

This site contains REAL public records data including criminal records, background reports, photos, court documents, address information, phone numbers, civil judgments, properties owned, social media ...

HYDERABAD July 23 (Reuters) - Dr Reddy's Laboratories (REDY.NS), opens new tab plans to launch a cheaper copycat version of Novo Nordisk's (NOVOb.CO), opens new tab blockbuster weight-loss drug Wegovy ...

Dr. Reddy’s Laboratories (NYSE:RDY) is preparing to launch a generic version of semaglutide, the active ingredient in Novo Nordisk’s (NVO) weight loss drug Wegovy, in 87 countries beginning in 2026, ...